Aedge Group Ltd
SGX:XVG
Aedge Group Ltd
SGX:XVG
Price:
0.37
SGD
Market Closed
Market Cap:
S$39.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aedge Group Ltd
SGX:XVG
|
SG |
|
C
|
Cutia Therapeutics
HKEX:2487
|
CN |
Balance Sheet
Balance Sheet Decomposition
Aedge Group Ltd
Aedge Group Ltd
Balance Sheet Decomposition is not available for
Aedge Group Ltd
Aedge Group Ltd
Balance Sheet
Aedge Group Ltd
Aedge Group Ltd
Currency: SGD
| Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
6
|
4
|
6
|
9
|
6
|
3
|
3
|
2
|
|
| Cash Equivalents |
6
|
4
|
6
|
9
|
6
|
3
|
3
|
2
|
|
| Total Receivables |
8
|
8
|
9
|
5
|
7
|
8
|
7
|
7
|
|
| Accounts Receivables |
8
|
8
|
9
|
5
|
7
|
8
|
7
|
7
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Total Current Assets |
14
|
11
|
15
|
15
|
13
|
12
|
11
|
10
|
|
| PP&E Net |
12
|
13
|
12
|
11
|
9
|
7
|
5
|
4
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
9
|
18
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
27
N/A
|
25
-8%
|
26
+7%
|
26
-1%
|
22
-14%
|
19
-14%
|
25
+31%
|
32
+29%
|
|
| Liabilities | |||||||||
| Accounts Payable |
3
|
3
|
5
|
3
|
3
|
3
|
4
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
2
|
5
|
4
|
4
|
3
|
3
|
3
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
5
|
5
|
10
|
7
|
7
|
6
|
6
|
10
|
|
| Long-Term Debt |
4
|
2
|
1
|
2
|
1
|
1
|
7
|
11
|
|
| Deferred Income Tax |
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
10
N/A
|
8
-14%
|
12
+42%
|
9
-19%
|
8
-13%
|
7
-11%
|
14
+89%
|
21
+55%
|
|
| Equity | |||||||||
| Common Stock |
12
|
12
|
12
|
15
|
15
|
15
|
15
|
15
|
|
| Retained Earnings |
5
|
5
|
3
|
2
|
0
|
3
|
3
|
4
|
|
| Total Equity |
17
N/A
|
16
-4%
|
15
-10%
|
17
+13%
|
14
-15%
|
12
-16%
|
11
-5%
|
11
-1%
|
|
| Total Liabilities & Equity |
27
N/A
|
25
-8%
|
26
+7%
|
26
-1%
|
22
-14%
|
19
-14%
|
25
+31%
|
32
+29%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
106
|
106
|
106
|
106
|
106
|
159
|
159
|
162
|
|
Switch to:
Switch to:
See Also
Discover More
